Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1996 | 06-1996 | 03-1996 | 12-1995 | 09-1995 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 25,135 | 18,417 | 20,013 | 18,417 | 6,881 |
| TOTAL | $25,135 | $18,417 | $20,013 | $18,417 | $6,881 |
| Non-Current Assets | |||||
| PPE Net | 230,655 | 229,871 | 220,081 | 219,013 | 216,599 |
| Investments And Advances | 8,353 | 0 | 6,972 | 0 | 4,393 |
| Other Non-Current Assets | 35,596 | 36,695 | 35,398 | 239,908 | 236,667 |
| TOTAL | $274,604 | $266,566 | $262,451 | $458,921 | $457,659 |
| Total Assets | $299,739 | $284,983 | $282,464 | $477,338 | $464,540 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,130 | 11,000 | 14,976 | 116,081 | 57,491 |
| Accounts payable and accrued liabilities | 14,765 | 15,119 | 16,919 | 18,531 | 14,049 |
| Accrued Expenses | 3,718 | 3,731 | 5,749 | 6,078 | 5,243 |
| TOTAL | $70,019 | $80,615 | $107,768 | $155,364 | $87,007 |
| Non-Current Liabilities | |||||
| TOTAL | $58,891 | $58,959 | $63,113 | $64,114 | $61,473 |
| Total Liabilities | $128,910 | $139,574 | $170,881 | $219,478 | $148,480 |
| Shareholders' Equity | |||||
| Common Shares | 48,052 | 48,358 | 58,063 | 57,843 | 0 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 161,632 |
| TOTAL | $68,483 | $69,740 | $114,171 | $107,592 | $161,632 |
| Total Liabilities And Equity | $197,393 | $209,314 | $285,052 | $327,070 | $310,112 |